{"version":"1.0","type":"link","title":"Long-term outcomes in -mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor.","author_name":"Short NJ 외","author_url":"https://prs-insight.online/author/Short%20NJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/159494","thumbnail_width":1200,"thumbnail_height":630}